Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China

Journal of Human Hypertension volume 29, pages 555–560 (2015)Cite this article

Subjects

Abstract

In the previous study, hypertension prevalence, awareness, treatment and control for Han and others four ethnic minorities (Uygur, Hui, Mongolian and Dai) has not been clearly documented in China. Therefore we used the baseline data of Prospective Urban and Rural Epidemiology (PURE) for further detailed study. Adjusted rate were estimated and compared through logistic regression after adjustment of age, sex, location and education. Among the total of 7137 participants (Han: 1626, ethnic minorities: 5511), hypertension prevalence, awareness, treatment and control were 2922(40.9%), 1199(41.0%), 873(29.9%) and 147(5.0%), respectively. The most commonly used antihypertensive drugs are traditional compound drugs (6.2%) and calcium channel blockers (5.2%). Hypertension prevalence in ethnic minorities was significantly higher than in Han (42.4% vs 34.4%, P<0.0001), while control rate (1.6% vs 9.8%, P=0.0198) and treated control rate (8.0% vs 25.0%, P=0.0200) were lower. Compared with Han counterparts, Dai had a higher prevalence (50.8% vs 29.9%, P<0.0001). Uygur had a lower treatment rate (33.2% vs 20.6%, P=0.0110). Mongolian had a lower control (5.1% vs 16.1%, P=0.0046) and treated control rate (14.1% vs 50.3%, P=0.0013). In conclusions, our study showed ethnic minorities had higher hypertension prevalence, especially for Dai and lower control and treated control rate for Mongolian. Hence, we need more attention with respect to hypertension in ethnic minorities.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. World Health Organization Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. World Health Organization: Geneva, 2009.

  2. Wang Q . High blood pressure a growing threat to China's public health[Internet]. China Daily (Beijing), c1995–2015. Available from: http://www.chinadaily.com.cn/cndy/2013-04/08/content_16381678.html (cited 7 September 2014).

  3. National Center for Cardiovascular Diseases Report on Cardiovascular Disease in China (2007) [in Chinese]. Encyclopedia of China Publishing House: Beijing, 2007.

  4. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P et al. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40 (6): 920–927.

    Article  CAS  Google Scholar 

  5. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118 (25): 2679–2686.

    Article  Google Scholar 

  6. Chow CK . Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310 (9): 959.

    Article  CAS  Google Scholar 

  7. Chen Z, Meltzer D . Beefing up with the Chans: evidence for the effects of relative income and income inequality on health from the China Health and Nutrition Survey. Soc Sci Med 2008; 66 (11): 2206–2217.

    Article  Google Scholar 

  8. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S and Group PI-W. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158 (1): 1–7 e1.

    Article  Google Scholar 

  9. Gao Y, Chen G, Tian H, Lin L, Lu J, Weng J et al. Prevalence of hypertension in china: a cross-sectional study. PLoS ONE 2013; 8 (6): e65938.

    Article  CAS  Google Scholar 

  10. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002; 40 (6): 920–927.

    Article  CAS  Google Scholar 

  11. Tao S, Wu X, Duan X, Fang W, Hao J, Fan D et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J 1995; 108 (7): 483–489.

    CAS  PubMed  Google Scholar 

  12. Wang Z, Wang X, Chen Z, Wang W, Zhu H, Chen W et al. Hypertension control in community health centers across china: analysis of antihypertensive drug treatment patterns. Am J Hypertens 2014; 27: 252–259.

    Article  CAS  Google Scholar 

  13. Yisong H, Chonghua Y, Wenzhi W, Jianpin H . Survey on the prevalence of hypertension in different ethnic groups in China in 2002. J Hypertens Res 2006; 35 (5): 573–575.

    Google Scholar 

  14. Ferdinand KC . Hypertension in minority populations. J Clin Hypertens 2006; 8 (5): 365–368.

    Article  Google Scholar 

  15. Centers for Disease Control. Prevention. Prevention. Racial/ethnic disparities in prevalence, treatment, and control of hypertension—United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2005; 54 (1): 7.

    Google Scholar 

  16. Yao X-G, Frommlet F, Zhou L, Zu F, Wang H-M, Yan Z-T et al. The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang. BMC Public Health 2010; 10 (1): 91.

    Article  Google Scholar 

  17. Lu Z, Lu Z, Zhu Y, Yan Z, Liu X, Yan S et al. Enhanced hypertension prevalence in non-Han Chinese minorities from Xinjiang Province, China. Hypertens Res 2009; 32 (12): 1097–1103.

    Article  Google Scholar 

  18. Yang S, Liu S, Wang Y, Wan H, Zhao D, Li Y et al. High blood pressure in Chinese ethnic minorities: report from rural Yunnan province. Am J Hypertens 2011; 24 (11): 1209–1214.

    Article  Google Scholar 

  19. He J, Klag MJ, Whelton PK, Chen JY, Mo JP, Qian MC et al. Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol 1991; 134 (10): 1085–1101.

    Article  CAS  Google Scholar 

  20. Black ML, Wang W, Bittles AH . A genome-based study of the Muslim Hui community and the Han population of Liaoning Province, PR China. Hum Biol 2001; 73 (6): 801–813.

    Article  CAS  Google Scholar 

  21. Gu Q, Burt VL, Dillon CF, Yoon S . Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 2012; 126 (17): 2105–2114.

    Article  CAS  Google Scholar 

  22. Ling RE, Liu F, Lu XQ, Wang W . Emerging issues in public health: a perspective on China's healthcare system. Public Health 2011; 125 (1): 9–14.

    Article  CAS  Google Scholar 

  23. Shao S, Zhao F, Wang J, Feng L, Lu X, Du J et al. The ecology of medical care in Beijing. PLoS ONE 2013; 8 (12): e82446.

    Article  Google Scholar 

  24. Liao Y, Tucker P, Okoro CA, Giles WH, Mokdad AH, Harris VB . REACH 2010 surveillance for health status in minority communities—-United States, 2001—2002. MMWR Surveill Summ 2004; 53 (6): 1–36.

    PubMed  Google Scholar 

  25. Zhang M, Meng Y, Yang Y, Liu Y, Dong C, Xiao J et al. Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China. BMC Public Health 2011; 11 (1): 301.

    Article  Google Scholar 

Download references

Acknowledgements

We wish to acknowledge the contribution of the participants to PURE-China study as well as local medical personnel for data collection.

Author information

Authors and Affiliations

  1. State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

    H Gu, W Li, J Yang, Y Wang, J Bo & L Liu

Authors
  1. H Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Bo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W Li.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gu, H., Li, W., Yang, J. et al. Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China. J Hum Hypertens 29, 555–560 (2015). https://doi.org/10.1038/jhh.2014.123

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2014.123

This article is cited by

Search

Advanced search

Quick links